Published in Acta Med Acad Sci Hung on January 01, 1975
On the mode of action of antianginal drugs. Basic Res Cardiol (1978) 0.75
Antifibrillatory action. J Physiol (1962) 3.36
Protective effects of preconditioning of the ischaemic myocardium involve cyclo-oxygenase products. Cardiovasc Res (1990) 2.51
Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res (1992) 1.86
Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br J Pharmacol (1992) 1.71
Naloxone inhibits early arrhythmias resulting from acute coronary ligation. Br J Pharmacol (1982) 1.53
[Significant increase of pectus excavatum cases in Tata between 1990 and 1992]. Orv Hetil (1998) 1.38
Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br J Pharmacol (1991) 1.21
Antiarrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischaemia. Br J Pharmacol (1983) 1.21
Effect of non-steroid anti-inflammatory drugs in experimental myocardial infarction in rats. Eur J Pharmacol (1981) 1.20
Effect of adenosine on sinoatrial and ventricular automaticity of the guinea pig. Naunyn Schmiedebergs Arch Pharmacol (1980) 1.16
The effects of prolonged oral administration of a new antidysrhythmic drug (Org 6001) on coronary artery ligation dysrhythmias in conscious and anesthetized rats. J Cardiovasc Pharmacol (1980) 1.14
Transient ischaemia induced by rapid cardiac pacing results in myocardial preconditioning. Cardiovasc Res (1991) 1.12
Effect of the blood supply to the normal noninfarcted myocardium on the incidence and severity of early post-occlusion arrhythmias in dogs. Basic Res Cardiol (1987) 1.10
The local intracoronary administration of methylene blue prevents the pronounced antiarrhythmic effect of ischaemic preconditioning. Br J Pharmacol (1992) 1.07
Nitroglycerin and dipyridamole on cardiac metabolism and dynamics in a new experimental model of angina pectoris. J Pharmacol Exp Ther (1976) 1.06
Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats. J Pharmacol Methods (1983) 1.01
Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs. Br J Pharmacol (1993) 1.01
The possible role of mast cells in pigmented nevi. Arch Dermatol Forsch (1974) 0.93
Are ATP sensitive potassium channels involved in the pronounced antiarrhythmic effects of preconditioning? Cardiovasc Res (1993) 0.91
The possible mechanism of protection induced by dexamethasone against sudden death due to coronary ligation in conscious rats. Br J Pharmacol (1983) 0.90
Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs. Eur J Pharmacol (1986) 0.89
Effect of actinomycin D and cycloheximide on experimental myocardial infarction in rats. Eur J Pharmacol (1982) 0.88
Proceedings: Function and metabolism of guinea pig atria incubated with various fatty acids under special consideration of arachidonic acid as a precursor of prostaglandins. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.87
7-oxo-PgI2 induced late appearing and long-lasting electrophysiological changes in the heart in situ of the rabbit, guinea-pig, dog and cat. J Mol Cell Cardiol (1989) 0.86
Protective effect of lidocaine against ischemia and reperfusion-induced arrhythmias and shifts of myocardial sodium, potassium, and calcium content. J Cardiovasc Pharmacol (1988) 0.85
The effect of beta-adrenoceptor blocking drugs on free fatty acid and glucose utilization of the isolated canine heart with normal and restricted flow in the presence and absence of noradrenaline. Acta Biol Med Ger (1978) 0.85
Pacing and reperfusion induced arrhythmias: protection by slow heart rate in the rat heart. Cardiovasc Res (1988) 0.83
Haemodynamic factors influencing myocardial ischaemia in a canine model of coronary artery stenosis: the effects of nitroglycerine. Br J Pharmacol (1983) 0.83
Antiarrhythmic compounds. Prog Drug Res (1968) 0.83
[On the testing of external corticoid with the Rebuck test]. Med Klin (1968) 0.83
Protective effects on verapamil and diltiazem against inorganic phosphate induced impairment of oxidative phosphorylation of isolated heart mitochondria. Biochem Pharmacol (1981) 0.82
The arrhythmogenic action of sympathomimetic amines. Eur J Pharmacol (1968) 0.82
Metoprolol reduces reperfusion-induced fibrillation in the isolated rat heart: protection is secondary to bradycardia. J Cardiovasc Pharmacol (1987) 0.82
Characteristics of the human skin bradykinin-destroying enzyme. J Med (1971) 0.82
Effect of arterial hypoxia on the susceptibility to arrhythmia of the heart. Acta Physiol Acad Sci Hung (1967) 0.81
Effect of dietary sunflower seed oil on the severity of reperfusion-induced arrhythmias in anesthetized rats. J Cardiovasc Pharmacol (1992) 0.81
Wound healing and fibrinolytic activity. Vasa (1973) 0.81
Delayed protection of the heart against ischaemia. Trends Pharmacol Sci (1995) 0.81
On the 7-oxo-PgI2 induced lasting protection against ouabain arrhythmias in anesthetized guinea pigs. Biomed Biochim Acta (1988) 0.80
Possible involvement of platelet activating factor in anaphylaxis of passively sensitised, isolated guinea pig hearts. Cardiovasc Res (1989) 0.80
Assay of antianginal drugs by relieving pituitrin induced coronary vasoconstriction in the intact unanaesthetized animal. Arch Int Pharmacodyn Ther (1966) 0.80
Moderate stress by cardiac pacing may induce both short term and long term cardioprotection. Cardiovasc Res (1993) 0.80
On the possible role of adenosine in the hypoxia-induced alterations of the electrical and mechanical activity of the atrial myocardium. Arch Int Pharmacodyn Ther (1979) 0.80
Analysis of the mechanism of adrenergic actions on ventricular vulnerability. Eur J Pharmacol (1968) 0.80
Electron microscopic investigation on the local cellular reaction to primary malignant melanoma. Dermatologica (1981) 0.79
Increased activity of sarcolemmal (Na+K+)-ATPase is involved in the late cardioprotective action of 7-oxo-prostacyclin. Cardioscience (1991) 0.79
The effects of arachidonic acid in isolated atria of guinea pigs. Eur J Pharmacol (1977) 0.79
Alterations of the clinically noninvolved skin in patients with malignant melanoma. An electron microscopic study before and after repeated application of BCG. Dermatologica (1978) 0.79
Electrophysiological changes induced by lysophosphatidylcholine, an ischaemic phospholipid catabolite, in rabbit atrial and ventricular cardiac cells. Acta Physiol Hung (1992) 0.79
The effects of metoprolol and dazmegrel, alone and in combination, on arrhythmias induced by coronary artery occlusion in conscious rats. Br J Pharmacol (1985) 0.79
Influence of stretch and dynamic functional state of the myocardium on tendency of the heart to arrhythmia. Acta Physiol Acad Sci Hung (1967) 0.79
Fine structure and x-ray microanalysis of melanosomes in pigmented nevi and melanomas. Arch Dermatol Forsch (1975) 0.79
Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade. Acta Biol Med Ger (1972) 0.79
Drug-induced augmentation of coronary flow in vessels with maximum ischemic dilatation. Arch Int Pharmacodyn Ther (1976) 0.79
Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs. Adv Myocardiol (1985) 0.79
Short incubation with 7-oxo-prostacyclin induces long lasting prolongation of repolarisation time and effective refractory period in rabbit papillary muscle preparation. Cardiovasc Res (1990) 0.78
Experimental myocardial infarction in adjuvant arthritis rats. J Cardiovasc Pharmacol (1982) 0.78
Suppression of reperfusion induced arrhythmias in the isolated rat heart: pretreatment with 7-oxo prostacyclin in vivo. Cardiovasc Res (1993) 0.78
Importance of myocardial blood flow changes in the protective action of diltiazem in a new model of myocardial ischaemia. Br J Pharmacol (1985) 0.78
Long lasting anti-adrenergic effect of 7-oxo-prostacyclin in the heart: a cycloheximide sensitive increase of phosphodiesterase isoform I and IV activities. Mol Cell Biochem (1994) 0.78
On the nature and molecular basis of prostacyclin induced late cardiac changes. Biomed Biochim Acta (1988) 0.78
[Structural variants of intracellular flagella and centrioles in nevus cells]. Z Hautkr (1975) 0.78
On the late antiischaemic action of the stable PgI2 analogue: 7-oxo-PgI2-Na and its possible mode of action. Biomed Biochim Acta (1984) 0.78
Prevention by 7-oxo-prostacyclin of the calcium paradox in rat heart: role of the sarcolemmal (Na,K)-ATPase. Mol Cell Biochem (1997) 0.78
On the mechanism and possible therapeutic application of delayed adaptation of the heart to stress situations. Mol Cell Biochem (1996) 0.78
Evaluation of the effect of Lake Hévíz thermal mineral water in patients with osteoarthritis of the knee: a randomized, controlled, single-blind, follow-up study. Eur J Phys Rehabil Med (2014) 0.78
Protective effect of 7-oxo-prostacyclin on myocardial function and metabolism during postischemic reperfusion and calcium paradox. Basic Res Cardiol (1992) 0.77
Investigations on the chemistry of berbanes. 10. Synthesis of raunescinone analogues with hypotensive and antihypertensive activity. J Med Chem (1984) 0.77
Effects of octanoate on the electrical activity of Purkinje fibres. Experientia (1974) 0.77
Actinomycin D suppresses the protective effect of dexamethasone in rats affected by global cerebral ischemia. Stroke (1985) 0.77
Two separate synchronizing mechanisms in the basal forebrain: study of the synchronizing effects of the rostral hypothalamus, preoptic region and olfactory tubercle. Arch Ital Biol (1979) 0.77
Cardiac effects of prostaglandins E2 and F2alpha. Arch Int Pharmacodyn Ther (1974) 0.77
7-oxo-PGI2 induced late protective action from arrhythmias due to local myocardial ischemia. Bratisl Lek Listy (1991) 0.77
Potentiation of the myocardial actions of adenosine in the presence of coformycin, a specific inhibitor of adenosine deaminase. Arch Int Pharmacodyn Ther (1982) 0.77
Cardiac actions of arachidonic acid. Acta Biol Med Ger (1976) 0.77
Comparison of two calcium antagonists, verapamil and fendiline, in an experimental model of myocardial ischaemia mimicking classical angina on effort. Br J Pharmacol (1983) 0.77
Comparative statistical analysis of osteoporosis treatment based on Hungarian claims data and interpretation of the results in respect to cost-effectiveness. Osteoporos Int (2014) 0.77
Prevention by macrocortin of global cerebral ischemia in Sprague-Dawley rats. Eur J Pharmacol (1984) 0.76
On the mode of action of antianginal drugs. Basic Res Cardiol (1978) 0.75
Ultrastructural changes of mitochondria in pigmented and halo nevi. Arch Dermatol Forsch (1974) 0.75
Nerves and nerve endings in pigmented nevi. Part II: Uncommon structural varieties. Arch Dermatol Forsch (1975) 0.75
[Studies on the role of bradykinin in certain dermatoses]. Arch Klin Exp Dermatol (1967) 0.75
Mechanism of increased susceptibility to fibrillation of the hypothermic mammalian heart in situ. Br J Pharmacol Chemother (1961) 0.75
Nifedipine effects in severe myocardial ischaemia in the dog due to left anterior descending coronary occlusion with left circumflex coronary artery constriction. Br J Pharmacol (1987) 0.75
Glucocorticoids in myocardial and cerebral infarction. Agents Actions (1986) 0.75
The effect of exaprolol (MG 8823) on epicardial ST-segment changes in a feline model of acute myocardial ischaemia. Br J Pharmacol (1983) 0.75
Effects of a combination of metoprolol and dazmegrel on myocardial infarct size in rats. Br J Pharmacol (1985) 0.75
Evoked potential study of the synchronizing and hypnogenic areas in the basal forebrain. Waking Sleeping (1979) 0.75